Open Care announces Immubio platform based on nanoparticle science, currently developing potential break-through COVID-19 immunisation
Open Care announces Immubio platform based on nanoparticle science, currently developing potential break-through COVID-19 immunisation MELBOURNE, Australia, Dec. 17, 2020 /PRNewswire/ -- Open Care (https://open.care) have announced the progress of their early-stage development of their potential COVID-19 Immunisation, ImmubioCV, based on Nanobiologics, a new approach centered on nanoparticles, water coherent domains and ultra dilutions that allows for the preparation of potentially safe, effective and readily scalable immunisations using a novel patent pending process. Open Care, the biotech...
Source: finanznachrichten.de